Home » Media Center » News » Gornitzky represents the underwriters, led by Wells Fargo, in RedHill Biopharma’s public offering of ADSs.

February 15, 2015

Gornitzky represents the underwriters, led by Wells Fargo, in RedHill Biopharma’s public offering of ADSs.

PDF

Gornitzky & Co. represented the underwriters, led by Wells Fargo, in RedHill Biopharma’s USD 14.4 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

Wells Fargo Securities acted as lead book-running manager and Roth Capital Partners acted as joint book-running manager for the offering. MLV & Co acted as co-manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.

Gornitzky represents the underwriters, led by Wells Fargo, in RedHill Biopharma’s public offering of ADSs.

KEY CONTACTS

Chaim Friedland

Ari Fried

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

Precedent-Setting Decision: Development Improvement Plans Within 100 Meters of the Shoreline

The Importance of Incoterms in International Trade

The war has had a major impact on foreign investments

Success in the Appeals Committee

Ronit Rozenstein-Barel delivers Lecture at the 2024 Energy and Business Conference

Yaron Elhawi Appointed as Debt Settlement Administrator for Kalit Sitbon Ltd.

Nona Lerner Wins the Client Choice Award in Arbitration

New EU Design Legislation: Modernizing Protection for the Digital Era

New Proposed Legislative Tax Reform regarding Corporate Reorganizations

Our Impact

Aviram Handel – Lecture at the Conference of the Court Administration for Legal Assistants at the Tel Aviv District Court